| Literature DB >> 12225376 |
Jiraprapa Wipasa1, Salenna Elliott, Huji Xu, Michael F Good.
Abstract
The development of a malaria vaccine seems to be a definite possibility despite the fact that even individuals with a life time of endemic exposure do not develop sterile immunity. An effective malaria vaccine would be invaluable in preventing malaria-associated deaths in endemic areas, especially amongst children less than 5 years of age and pregnant women. This review discusses our current understanding of immunity against the asexual blood stage of malaria - the stage that is responsible for the symptoms of the disease - and approaches to the design of an asexual blood stage vaccine.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12225376 DOI: 10.1046/j.1440-1711.2002.01107.x
Source DB: PubMed Journal: Immunol Cell Biol ISSN: 0818-9641 Impact factor: 5.126